Insights from Digital Pharma Leaders
Refine Search
Pharmaceutical
An Expert View from Kevin Wild, head of pre-sales at software company Syniti. 23 January 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 January 2025
Pharmaceutical
French pharmaceutical company Servier and Google Cloud have announced an expanded five-year partnership aimed at leveraging artificial intelligence (AI) and generative AI to accelerate drug research and development. 16 January 2025
Pharmaceutical
A collection of some of the largest US health systems, in collaboration with the Regeneron Genetics Center, have announced the launch of the Truveta Genome Project. 16 January 2025
Pharmaceutical
Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a licensing deal with AI-driven biotech Insilico Medicines. 15 January 2025
Biotechnology
Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease indication. 13 January 2025
Pharmaceutical
Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co. 13 January 2025
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
A team of Chinese researchers has identified a promising candidate for glaucoma treatment using artificial intelligence tools. 6 January 2025
Pharmaceutical
The market for artificial intelligence (AI) in cancer care is projected to grow from $2.2 billion in 2024 to $6.3 billion by 2029, reflecting a growth rate of 23.1%, according to a recent study by BCC Research. 31 December 2024
Biotechnology
AI-driven biotech BenevolentAI has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. 20 December 2024
Pharmaceutical
Shanghai-based Fangzhou, has entered into a strategic partnership with the Chinese business of Bristol Myers Squibb China, with the goal of enhancing digital platforms for chronic disease management. 19 December 2024
Pharmaceutical
Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private placement, supporting a planned expansion into the UK. 16 December 2024
Pharmaceutical
The pharmacovigilance (PV) teams within the pharmaceutical industry currently report allocating 40 to 85% of budgets towards case processing. With case processing volumes growing at a rate of 10 to 15% annually, life sciences organizations are aiming to reduce costs and automate time-consuming processes while maintaining or improving quality. 9 December 2024
Biotechnology
Boston-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, has entered a research collaboration and option agreement with US pharma major Bristol Myers Squibb. 4 December 2024
Pharmaceutical
A Feature on M&A, licensing, and partnership tapping into AI’s potential to improve drug development. 2 December 2024
Biotechnology
AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now raised more than $100 million in total, calls itself the leading platform for AI-powered protein engineering. 27 November 2024
Biotechnology
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Pharmaceutical
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024
Biotechnology
The life sciences landscape has adapted in tandem with data management solutions over the past several years, attracting significant investment. However, these solutions lack the ability to rapidly address and complement existing pain points and previous investments with the latest technological innovations. 3 January 2024
Biotechnology
A new collaboration between Washington, USA-based Absci and UK-based AstraZeneca will see the firms working together to discover new cancer treatments. 4 December 2023
Pharmaceutical
A new artificial intelligence (AI)-based model developed by scientists at ETH Zurich could help determine optimal synthesis methods for new active pharmaceutical ingredients (API). 27 November 2023
Pharmaceutical
Nobody could call it a good week for Bayer, with its shares slumping to their lowest level in a decade on Monday after the firm said it would discontinue a Phase III trial for a blood-thinning drug for heart disease that had failed to demonstrate efficacy. 23 November 2023
Pharmaceutical
The UK’s largest drugmaker, AstraZeneca, has announced the launch of a new AI-focused digital health solutions company, to be called Evinova. 20 November 2023
Pharmaceutical
Spanish dermatology specialist Almirall and US generative AI drug creation company Absci Corporation have announced a drug discovery partnership. 14 November 2023
Pharmaceutical
Germany’s Bayer and Recursion Pharmaceuticals, a US techbio firm seeking to decode biology to industrialize drug discovery, have updated the focus of their research collaboration to precision oncology. 10 November 2023
Pharmaceutical
Life science compliance specialist Model N has announced product enhancements relating to the Inflation Reduction Act. 8 November 2023
Biotechnology
French venture capital firm Sofinnova Partners has announced the closing of a $200 million fund, spearheaded by partners Edward Kliphuis and Simon Turner. 27 October 2023
Biotechnology
As drugmakers around the world rush to embrace the potential of artificial intelligence (AI) in the design and development of new medications, the World Health Organization has urged caution. 23 October 2023
Pharmaceutical
On Wednesday, the US Food and Drug Administration (FDA) announced the creation of a new Digital Health Advisory Committee. 12 October 2023
Biotechnology
A company founded by Flagship Pioneering, Generate Biomedicines, has raised over a quarter of a billion dollars in a series C financing round. 14 September 2023
Biotechnology
Japanese mid-size drugmaker Otsuka Pharmaceutical has inked a deal with ShapeTX, a specialist in programmable medicines. 8 September 2023
Pharmaceutical
A new report from British market research firm Deep Pharma Intelligence provides a profile of the use of artificial intelligence in the drug discovery industry. 17 August 2023
Pharmaceutical
A feature analyzing the recent investment activity in digital technologies and AI. 11 August 2023
Pharmaceutical
The European Medicines Agency (EMA) has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of medicines. 19 July 2023
Pharmaceutical
Developing new drugs is a complex and expensive process with a high failure rate. In fact, only about one out of 250 preclinical compounds make it to FDA approval. With an average cost of $40,000 per patient in a phase three clinical trial, the financial impact of failure is staggering. 4 July 2023
Pharmaceutical
French drugmaker Sanofi has placed a strong emphasis on the adoption of artificial intelligence capabilities to facilitate its internal operations. 13 June 2023
Pharmaceutical
Chinese artificial intelligence company XtalPi has agreed terms for a $250 million collaboration with Eli Lilly. 31 May 2023
Pharmaceutical
The life sciences industry has always been subjected to transparency requirements. To help avoid compliance violations that may lead to penalties, many life science organizations have ramped up their efforts to collect compliance data and streamline the reporting process. 10 May 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze